Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)

CUSIP: 98943L107

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock,$0.001 par value per share
Shares outstanding
72,096,078
Total 13F shares
81,068,438
Share change
+828,482
Total reported value
$1,228,198,230
Put/Call ratio
3.5%
Price per share
$15.15
Number of holders
118
Value change
-$21,970,408
Number of buys
60
Number of sells
68

Quarterly Holders Quick Answers

What is CUSIP 98943L107?
CUSIP 98943L107 identifies ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) as of Q4 2023

As of 31 Dec 2023, Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) was held by 118 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 81,068,438 shares. The largest 10 holders included Matrix Capital Management Company, LP, EVENTIDE ASSET MANAGEMENT, LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, CITADEL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, and T. Rowe Price Investment Management, Inc.. This page lists 118 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.